-
-
12/02/2024 13/02/2024 America/Toronto Pathways To Access & Reimbursement Pathways To Access & Reimbursement
February 12 – 13, 2024
One King West Hotel, Toronto, ON
Please visit https://www.canadianinstitute.com/pathways-access-reimbursement/ for more information and updates. One King West Hotel, Toronto, ON true DD/MM/YYYY 1440 use-title -
-
-
12/02/2024 13/02/2024 America/Toronto Pathways To Access & Reimbursement Pathways To Access & Reimbursement
February 12 – 13, 2024
One King West Hotel, Toronto, ON
Please visit https://www.canadianinstitute.com/pathways-access-reimbursement/ for more information and updates. One King West Hotel, Toronto, ON true DD/MM/YYYY 1440 use-title -
Biosimilars in Canada: Assessing Barriers, and Benchmarking with Early Adopters
Jessica Arias
Manager, Provincial Drug Reimbursement Programs Clinical Institutes & Quality Programs
Ontario Health
Tijana Fazlagic
Executive Director of Therapeutic Assessment & Access Pharmaceutical, Laboratory & Blood Services Division
BC Ministry of Health
Helen Stevenson
Founder & CEO
Reformulary Group Inc.
Rosemarie Childerhose
Head, Market Access & Pricing
Biocon Biologics
- Analyzing how the biosimilars listings differ across the country by province
- Benchmarking with BC as the first province to implement a non-medical biosimilars switch policy
- How have switch policies impacted patients and provincial budgets
- Identifying remaining barriers to access across therapeutic areas and improving clinician support
- Assessing how provincial policies are impacting private plans
- Learn about the Pan-Canadian Oncology Biosimilars Initiative and how it shaped the implementation of oncology biosimilars in Canada
- Examining outputs from the initiative, including education materials, a real-world evidence
- Analysis of trastuzumab (reference v biosimilar), and oncology-specific utilization data for Ontario